Gene therapy strategies for the treatment of pituitary tumours

Journal of Molecular Endocrinology

Volumn 22, Issue 1, 1999, Pages 9-18

  Castro, M G ^a  

^a Molecular Medicine Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; NERVE GROWTH FACTOR; PROTEIN P53; THYMIDINE KINASE; VASCULOTROPIN; VIRUS VECTOR;

ADENOVIRUS; ANGIOGENESIS; CELL CYCLE; GENE THERAPY; HUMAN; HYPOPHYSIS TUMOR; LONG TERMINAL REPEAT; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; TRANSGENE; TUMOR SUPPRESSOR GENE; VIRUS CELL INTERACTION; VIRUS GENE;

ADENOMA; ADENOVIRUSES, HUMAN; ANTIMETABOLITES; ANTIVIRAL AGENTS; CELL CYCLE; DEFECTIVE VIRUSES; DEPENDOVIRUS; DNA REPLICATION; DNA, RECOMBINANT; DRUG CARRIERS; GENE THERAPY; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; GROWTH SUBSTANCES; HUMANS; LIPOSOMES; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; PITUITARY NEOPLASMS; PRODRUGS; RECEPTORS, GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; THYMIDINE KINASE;

EID: 0032941018     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0220009     Document Type: Review

References (88)

1. Acsadi G, Dickson G, Love DR, Jani A, Walsh FS, Gurunsinghe A, Wolff JA & Davies KE 1991 Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352 815-818.
2. Adams CBT & Burke CW 1993 Current modes of treatment of pituitary tumours. British Journal of Neurosurgery 7 123-128.
3. Bajocchi G, Feldman SH, Crystal RG & Mastrangeli A 1993 Direct in vivo gene transfer into ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genetics 3 229-234.
4. Bates AS, Farrell WE, Bicknell EJ, McNicol AM, Talbot AJ, Broome JC, Perrett CW, Thaker RV & Clayton RN 1997 Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. Journal of Clinical Endocrinology and Metabolism 82 818-824.
5. Bender MA, Palmer TD, Gelinas RE & Miller AD 1987 Evidence that the packaging signal of moloney murine leukemia virus extends into the gag region. Journal of Virology 61 1639-1646.
6. Berglund P, Sjoberg M, Garoff H, Atkins GJ, Sheahan BJ & Liljestrom P 1993 Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Biotechnology 11 916-920.
7. Bevan JS, Webster J, Burke CW & Scanlon MF 1992 Dopamine agonists and pituitary tumour shrinkage. Endocrine Reviews 13 220-240.
8. Blomet U, Naldini L, Kafri T, Trono D, Verma IM & Gage FH 1997 Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. Journal of Virology 71 6641-6649.
9. Braba M, Rajan B, Traish D & Ashley S 1993 The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clinical Endocrinology 38 571-578.
10. Brown OA, Santer RM, Shering AF, Larregina AT, Morelli AE, Southgate TD, Castro MG & Lowenstein PR 1997 Gene transfer into enteric neurons of the rat small intestine in organ culture using a replication defective recombinant herpes simplex virus type 1 (HSV1) vector, but not recombinant adenovirus vectors. Gene Therapy 4 331-338.
11. Brown PO, Bowerman B, Varmus HE & Bishop JM 1989 Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein. Proceedings of the National Academy of Sciences of the USA 86 2525-2529.
12. Castro MG, Goya RG, Sosa YE, Rowe J, Larregina A, Morelli A & Lowenstein PR 1997 Expression of transgenes in normal and neoplastic anterior pituitary cells using recombinant adenoviruses: long term expression cell cycle dependency, and effects on hormone secretion. Endocrinology 138 2184-2194.
13. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL & Marx SJ 1997 Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276 404-1-07.
14. Chiocca EA 1998 Experimental and clinical gene therapies for brain tumors: In Gene Therapy for Neurological Disorders and Brain Tumours, ch 11, pp 191-203. Eds EA Chiocca & XO Breakefield. Totowa, NJ: Humana Press.
15. Davis HL, Whalen RG, Demeneix BA 1993 Direct gene transfer into skeletal muscle in viro: factors affecting efficiency of transfer and stability of expression. Human Gene Therapy 4 151-159.
16. Dewey RA, Rowe J, Forrest Z, Morelli A, Klatzmann D, Wilkinson G, Lowenstein PR & Castro MG 1997 Adenovirus vectors for gene therapy of brain tumours. Abstracts of the Society for Neuroscience, part 2, 2447, no. 951.5.
17. Driman DK, Korbin MS, Kudlow JE & Asa SL 1992 Transforming growth factor-α in normal and neoplastic human endocrine tissue. Human Pathology 23 1360-1365.
18. Elias KA & Weiner RI 1984 Direct arterial vascularization of estrogen-induced prolactin secreting anterior pituitary tumors. Proceedings of the National Academy of Sciences of the USA 81 4549-4554.
19. Ezzat S, Walpola IA, Ramyar L, Smyth HS & Asa SKL 1995 Membrane anchored expression of transforming growth factor-α in human pituitary adenoma cells. Journal of Clinical Endocrinology and Metabolism 80 534-539.
20. Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M & Felgner PL 1994 Enhanced gene delivery and mechanism studies with a novel series of cational lipid formulations. Journal of Biological Chemistry 269 2550-2561.
21. Fisher KJ, Jooss K, Alston J, Yang Y, Haecker SE, High K, Pathak R, Raper SE & Wilson JM 1997 Recombinant adeno-associated virus for muscle directed gene therapy. Nature Medicine 3 306-312.
22. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL & Abraham GN 1993 The 'bystander effect': tumor regression when a fraction of the tumor mass is genetically modified. Cancer Research 53 5274-5283.
23. Freese A, During MJ, Davidson BL, Gennarelli TA, Kaplitt MG, Flamm ES & Snyder RJ 1996 Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin release. Journal of Clinical Endocrinology and Metabolism 81 2401-2404.
24. Fuller DH & Haynes JR 1994 A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Research and Human Retroviruses 10 1433-1441.
25. Geddes BJ, Harding TC, Hughes DS, Byrnes AP, Lightman SL, Conde G & Uney JB 1996 Persistent transgene expression in the hypothalamus following stereotaxic delivery of a recombinant adenovirus: suppression of the immune response with cyclosporin. Endocrinology 137 5166-5169.
26. Geddes BJ, Harding TC, Lightman SL & Uney JB 1997 Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin. Nature Medicine 3 1402-1404.
27. Gossen MA, Bonin AL, Freundlieb S & Bujard H 1994 Inducible gene expression systems for higher eukaryotic cells. Current Opinion in Biotechnology 5 516-520.
28. Hermens WT & Verhaagen J 1997 Adenoviral vector-mediated gene expression in the nervous system of immunocompetent Wistar and T cell-deficient nude rats: preferential survival of transduced astrogial cells in nude rats. Human Gene Therapy 8 1049-1063.
29. Higgins GA, Koh S, Chen KS & Gage FH 1989 NGF receptor gene expression and cholinergic neuronal hypertrophy within the basal forebrain of the adult rat. Neuron 3 247-256.
30. 1Δ20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9 1021-1027.
31. Ilan Y, Jona VK, Sengupta K, Davidson A, Horwitz MS, Chowdbury NR & Chowdhury JR 1997 Transient immunosuppression with FK506 permits long term expression of therapeutic genes introduced into the liver using recombinant adenvoiruses in the rat. Hepatology 26 949-956.
32. Jiao S, Williams P, Berg RK, Hodgeman BA, Liu L, Repetto G & Wolff JA 1992 Direct gene transfer into nonhuman primate myofibers in vivo. Human Gene Therapy 3 21-33.
33. Jooss K, Ertl HCJ & Wilson JM 1996 Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Human Gene Therapy 7 1555-1566.
34. Kay MA, Liu D & Hoogerbrugges PM 1997 Gene therapy. Proceedings of the National Academy of Sciences of the USA 94 12744-12746.
35. Kozarsky KF & Wilson JM 1993 Gene therapy: adenovirus vectors. Current Opinion in Genetics and Development 3 499-503.
36. LeRiche VK, Asa SL & Ezzat S 1996 Epidermal growth factor and its receptor (EGF-R) correlates with tumour aggressiveness. Journal of Clinical Endocrinology.and Metabolism 81 656-662.
37. Levy A & Lightman SL 1993 The pathogenesis of pituitary adenomas. Clinical Endocrinology 38 559-570.
38. Levy A & Lightman SL 1994 Diagnosis and management of pituitary tumours. British Medical Journal 308 1087-1091.
39. Levy A, Hall L, Yeudall WA & Lightman S 1994 p53 gene mutations in pituitary adenomas: rare events. Clinical Endocrinology 41 809-814.
40. Levi-Montalcini R 1987 The nerve growth factor 35 years later. Science 237 1154-1162.
41. Li Y, Koga M, Kasayam S, Matsumoto K, Arita N, Hayakawa T & Sato B 1992 Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas. Journal of Clinical Endocrinologv and Metabolism 75 1436-1441.
42. Lowenstein PR 1997 Why are we doing so much cancer gene therapy? Disentangling the scientific basis from the origins of gene therapy. Gene Therapy 4 755-756.
43. Lowenstein PR, Morrison E, McKee T, Stow ND, Preston CM, Clissold, P & Castro MG 1994 Use of recombinant vectors derived from herpes simplex virus I mutant tsK for short term expression of genes encoding cytoplasmic and membrane anchored proteins in postmitotic neurones and glial cells in vitro. Neuroscience 60 1059-1077.
44. Lowenstein PR, Shering AF, Bain D, Castro MG & Wilkinson GWG 1996 The use of adenovirus vectors to transfer genes to identified target brain cells in vitro. In Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders, ch 8, pp 93-114. Eds PR Lowenstein & LW Enquist. London: John Wiley & Sons.
45. Lowrie DB, Tascon RE, Colston MJ & Silva CL 1994 Towards a DNA vaccine against tuberculosis. Vaccine 12 1537-1540.
46. McAndrew J, Paterson AJ, Asa SL, McCarthy KJ & Kudlow JE 1995 Targeting ot transforming growth factor-α expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 136 4479-4488.
47. McCown TJ, Xiao X, Li J, Bresse GR & Samulski RJ 1996 Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Research 713 99-107.
48. Maione TE, Gray GS, Hunt AJ & Sharpe RJ 1991 Inhibition to tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Research 51 2077-2083.
49. Marcel T & Grausz JD 1997 The TMC worldwide gene therapy enrolment report, end 1996. Human Gene Therapy 8 775-800.
50. Massie B, Couture F, Lamoureaux L, Mosser DD, Guilbault C, Joliceour P, Belanger F & Yves Langelier 1998 Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette. Journal of Virology 72 2289-2296.
51. Milauer B, Shawyer LK, Plate KH, Risau W & Ullrich A 1994 Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367 576-578.
52. Miller AD 1992 Retroviral vectors. Current Topics in Microbiology and Immunology 158 1-24.
53. Miller DG, Adam MA & Miller AD 1990 Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Molecular and Cellular Biology 10 1239-1242.
54. Missale C, Castelletti L, Boroni F, Memo M & Spano PF 1991 Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line. Endocrinology 128 13-20.
55. Missale C, Boroni F, Losa M, Giovanelli M, Zanellato A, Dal Toso R, Balsari A & Spano PR 1993 Nerve growth factor suppresses the transforming phenotype of human prolactinomas. Proceedings of the National Academy of Sciences of the USA 90 7961-7965.
56. Miyoshi H, Takahashi M, Gage FH & Verma IM 1997 Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proceedings of the National Academy of Sciences of the USA 94 10319-10323.
57. Molitch ME 1989 Management of prolactinomas. Annual Review of Medicine 40 225-232.
58. Moolten FL 1986 Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Research 46 5276-5281.
59. Moolten FL 1994 Drug sensitivity ('suicide') genes for selective cancer chemotherapy. Cancer Gene Therapy 1 279-287.
60. Moss B 1996 Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proceedings of the National Academy of Sciences of the USA 93 11341-11348.
61. Nabel EG, Yang Z, Plautx G, Forough R, Zhan Y, Haudenschild CC, Maciag T & Nabel GJ 1993 Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 362 844-846.
62. Kipt display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumours. Cell 85 707-720.
63. Naldini L, Blomer U, Gage FH, Trono D & Verma I 1996a Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proceedings of the National Academy of Sciences of the USA 93 11382-11389.
64. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM & Trono D 19966 In vivo gene delivery and stable transduction of non dividing cells by a lentiviral vector. Science 272 263-267.
65. Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA & Graham FL 1996 A helper dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proceedings of the National Academy of Sciences of the USA 93 13565-13570.
66. Redekop GJ & Naus CCG 1995 Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth. Journal of Neurosurgery 82 83-90.
67. +/- mice. Nature Medicine 2 1316-1321.
68. Saleh M, Stacker SA & Wilks AF 1996 Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Research 56 393-401.
69. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M & Fukui M 1995 Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Research 55 1189-1193.
70. Shenk T 1996 Adenoviridae: the viruses and their replication. In Field Virology, edn 3, ch 30, pp 979-1016, Eds BN Fields, DM Knipe, PM Howley et al. Philadelphia: Lippincott-Raven.
71. Shering AF, Bain D, Stewart K, Epstein AL, Castro MG, Wilkinson GWG & Lowenstein PR 1997 Cell-type specific expression in brain cell cultures from the short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors. Journal of General Virology 78 445-459.
72. Shimon I & Melmed S 1997 Genetic basis of endocrine disease. Pituitary tumour pathogenesis. Journal of Clinical Endocrinology and Metabolism 82 1675-1681.
73. Smith JG, Raper SE, Wheeldon EB, Hackney D, Judy K, Wilson JM & Ect SL 1997 Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response. Human Gene Therapy 8 943-954.
74. Snyder RO, Miao CH, Patijin GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR & Kay MA 1997 Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genetics 16 270-276.
75. Stepien H, Grochal M, Zielinski KW, Mucha S, Kunert-Radek J, Kulig A, Stawowy A & Pisarek H 1996 Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma. Journal of Endocrinology 150 99-106.
76. Takachi A, Uozumi T, Kawamoto K, Ito A, Kurisu K & Sudo K 1994 Inhibitory effect of TNP-470, a new antiangiogenic agent, on the estrogen induced rat pituitary tumors. Anticancer Research 14 157-162.
77. Thapar K, Kovacs K & Laws ER 1997 Pituitary tumours. In Cancer of the Nervous System, ch 19, pp 363-403. Eds PMcL Black and JS Loeffler. Oxford: Blackwell Science.
78. Varmus HE, Shank PR, Hughs SE, King H-J, Heasley S, Majors J, Vogt PK & Bishop JM 1979 Synthesis, structure, and integration of the DNA of RNA tumor viruses. Cold Spring Harbour Symposium. Quantitative Biology 43 851-864.
79. Verma IM & Somia N 1997 Gene therapy: promises, problems and prospects. Nature 389 239-242.
80. Vile RG & Hart IR 1993 Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Research 53 3860-3864.
81. Webster RG, Fynan EF, Santoro JC & Robinson H 1994 Protection of ferrets against influenza challenge with a DNA vaccine to the hemagglutinin. Vaccine 12 1495-1498.
82. Wilson CB 1990 Role of surgery in the management of pituitary tumours. Neurosurgery Clinics of North America 1 139-159.
83. Windeatt S, Dewey RA, Perone MJ, Gonzalez-Nicolini V, Larregirm A, Morris I, Lowenstein PR & Castro MG 1998 Use of herpes simplex type 1 thymidine kinase (HSV1-TK) for gene therapy treatment of pituitary adenomas. Abstracts of the Society for Neuroscience, part 2, 2165, no. 859.6.
84. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A & Feigner PL 1990 Direct gene transfer into mouse muscle in vivo. Science 247 1465-1468.
85. Wood MJA, Charlton HM, Wood KJ, Kajiwara K & Byrnes AP 1996 Immune-responses to adenovirus vectors in the nervous system. Trends in Neurosciences 19 497-501.
86. Xiao X, Li J & Samulski RJ 1996 Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. Journal of Virology 70 8098-8108.
87. Zhuang Z, Ezzat SZ, Vortmeyer AO, Weil R, Oldfield EH, Park WS, Pack S, Huang S, Agarwal SK, Guru SC, Manickam P, Debelenko LV, Kester MB, Olufemi SE, Heppner C, Crabtree JS & Burns L 1997 Mutations of the MEN1 tumour suppressor gene in pituitary tumours. Cancer Research 57 5446-5451.
88. Zsengeller ZK, Wert SE, Hull WM, Hu X, Yei S, Trapnell BC & Whitsett JA 1995 Persistenee of replication-deficient adenovirus-mediated gene transfer in lungs of immunedeficient (nu/nu) mice. Human Gene Therapy 6 457-467.